NewAmsterdam Pharma Company NV has approved the grant of inducement share options for a new non-executive hire. The grant covers a total of 20,000 ordinary shares, with an exercise price of $35.20 per share, reflecting the closing market price on January 2, 2026. The options will vest over four years, with 25% vesting after the first year and the remaining shares vesting in equal monthly installments over the following three years, contingent on continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9620125-en) on January 05, 2026, and is solely responsible for the information contained therein.